662-04-012 ISMRM Abstract

Complexed Signal Average for Prostatic DWI: Improving Diagnostic Performance of Malignant from Benign Prostatic Areas on DWIs

Primary: Body - Prostate

Secondary: Diffusion - Diffusion Acquisition

662-04-012 · Artificial Intelligence-Based Image Reconstruction in the Body · Thursday, 14 May, 2:35 PM–3:30 PM · Digital Posters Row C

Keywords: Diffusion Acquisition Diffusion-Weighted Imaging Body Imaging Diagnostic differentiation Prostate cancer

Accepted

Takahiro Ueda¹, Natsuka Yazawa², Kaori Yamamoto², Yuichiro Sano², Masato Ikedo², Masanori Ozaki², Masahiko Nomura^1,3, Takeshi Yoshikawa^1,4, Daisuke Takenaka^1,5, Masahiro Endo^1,6, Yoshiyuki Ozawa¹, Yoshiharu Ohno ^1,3

¹Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan

²Canon Medical Systems Corporation, Otawara-shi, Japan

³Joint Research Laboratory of Advanced Medical Imaging & Artificial Intelligence, Fujita Health University School of Medicine, Toyoake, Japan

⁴Radiology, Fujita Health University Bantane Hospital, Nagoya, Japan

⁵Radiology, Fujita Health University Okazaki Medical Center, Okazaki, Japan

⁶Diagnostic Radiology, Shizuoka Cancer Center, Sunto-gun, Japan

Presenting Author: Yoshiharu Ohno

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Kitajima K, Takahashi S, Ueno Y, et al. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm2) and standard high b-value (1000 s/mm2). J Magn Reson Imaging. 2012 Jul;36(1):198-205.

2. Ueno Y, Kitajima K, Sugimura K, et al. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI. J Magn Reson Imaging. 2013 Jul;38(1):154-60.

3. Hausmann D, Aksöz N, von Hardenberg J, et al. Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer? Eur Radiol. 2018 Feb;28(2):869-876.

4. Tavakoli AA, Kuder TA, Tichy D, et al. Measured Multipoint Ultra-High b-Value Diffusion MRI in the Assessment of MRI-Detected Prostate Lesions. Invest Radiol. 2021 Feb 1;56(2):94-102.

5. Tamada T, Kido A, Ueda Y, et al. Clinical impact of ultra-high b-value (3000 s/mm(2)) diffusion-weighted magnetic resonance imaging in prostate cancer at 3T: comparison with b-value of 2000 s/mm(2). Br J Radiol. 2022 Mar 1;95(1131):20210465.

6. Ueda T, Ohno Y, Yamamoto K, et al. Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging. Radiology. 2022 May;303(2):373-381.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/662-04-012